Real-World Data Sources: EHRs, Claims, Registries & Clinical Notes Compared

Real-world data sources aren't interchangeable, and treating them that way is a common mistake in study design. EHRs, claims data, registries, and clinical notes each capture a different slice of a patient's care, with different strengths, different blind spots, and a different amount of work required before any of it is actually usable. This piece compares the four main real-world data sources sponsors and CROs draw on, what each one is genuinely good at, where each one falls short, and how they tend to get combined in practice.

What Counts as Real-World Data

Real-world data is health information generated outside a clinical trial, through the ordinary business of treating patients. It isn't one thing. It's a category that spans structured records, billing transactions, registry entries, and free-text documentation, each produced for a different operational reason, and each requiring its own approach before it's research-ready.

Electronic Health Records (EHR)

EHR data comes closer than most sources to a complete clinical picture of a single patient, since it captures diagnoses, vitals, lab orders, prescriptions, and visit notes in one system. The catch is that EHR data lives across thousands of largely non-interoperable systems. A patient seen at three different practices ends up with three separate partial records, and reconciling them takes either a data-sharing agreement or a network broad enough to see all three natively.

It's also uneven in how much of it is genuinely structured. Diagnosis codes and lab values tend to be clean. Symptom severity, functional status, and the reasoning behind a treatment decision usually aren't, they're written into the note rather than logged as a field.

Medical Claims Data

Claims data gets generated every time a provider bills for a service, and that's its biggest strength: breadth. A claims database can span millions of patients across a huge footprint of providers and payers, because billing is close to universal. Vendors like Optum and IQVIA have built entire businesses on exactly this kind of scale.

What claims data can't do is tell you much about clinical nuance. A claim proves a diagnosis code was billed and a procedure happened. It says nothing about a lab value, an imaging finding, or how a patient actually responded to treatment. For a study that needs population counts and treatment patterns, claims data is often enough on its own. For anything that needs functional or disease-severity detail, it usually isn't.

Patient and Disease Registries

Registries are purpose-built around a specific disease or patient population, which gives them a level of clinical depth EHR and claims data typically don't have. A well-run registry captures standardized assessments and longitudinal follow-up collected specifically for research, not incidentally as a byproduct of billing or documentation.

The trade-off is size and independence. Registries tend to be considerably smaller than claims databases, and quite a few carry sponsor relationships that raise fair questions about independence when the data supports that same sponsor's regulatory submission.

Clinical Notes and Unstructured Documentation

Clinical notes are where most of the detail that actually matters for a study lives, and also where it's hardest to reach. Relapse history, symptom severity, functional decline, the clinician's reasoning behind a treatment change, none of it typically exists as a coded field. It exists as a sentence in a progress note or a consult summary.

Extracting usable data from clinical notes takes natural language processing built for the specific clinical domain in question. General-purpose extraction tools tend to plateau well before they can reliably handle negation, temporal context, or specialty terminology, which is exactly the kind of nuance a field like neurology depends on to make the data usable at all.

Comparing the Four Source Types

Source	Strength	Limitation	Best Used For
EHR	Full clinical picture per patient	Fragmented across systems, unevenly structured	Diagnosis, treatment history, care pathways
Claims	Broad population coverage	Minimal clinical detail	Population counts, treatment patterns, utilization
Registries	Deep, standardized clinical detail	Small sample size, possible sponsor bias	Natural history, longitudinal outcomes
Clinical notes	Richest source of clinical nuance	Requires domain-specific extraction	Symptom severity, functional status, disease staging

Why the Right Combination Matters

No single source answers every research question, and most credible real-world evidence studies end up combining at least two. A feasibility count might start with claims data for breadth, then narrow using EHR-derived clinical criteria. A natural history baseline might draw on registry data supplemented with note-level detail that structured EHR fields never captured in the first place. Which combination works depends entirely on what the study needs to prove, and getting that wrong is a common reason real-world evidence studies get challenged on methodology rather than clinical logic.

The Common Thread: Getting to Usable, Structured Data

All four sources share the same underlying problem. Getting from raw record to research-ready data takes real work, no matter where you start. Even clean EHR fields need standardization across systems. Claims data needs linking and de-duplication. Registries need matching against exclusion criteria. Clinical notes need extraction that can handle clinical nuance without inventing an answer that isn't actually in the text. Which source you pick matters less, in the end, than whether you can get usable data out of it at the scale a study actually requires.

How NeuroDiscovery AI Works With Real World Data Sources

NeuroDiscovery AI focuses specifically on the source type most platforms struggle with: unstructured clinical documentation. The platform extracts structured variables directly from clinical notes and other free-text sources, across a base of 6M+ patient records and 3M+ active patients, spanning 1,000+ providers and 100+ clinical sites in 16+ U.S. states. That focus complements EHR and claims-based approaches rather than replacing them, built to recover the clinical detail those more structured sources were never designed to hold.

Conclusion

EHRs, claims data, registries, and clinical notes each answer a different kind of question, and none of them substitutes fully for the others. Which sources get chosen should follow from what a study actually needs to prove, not from whichever dataset happens to be easiest to access. In neurology specifically, where much of the clinically meaningful detail sits in free text rather than coded fields, the ability to extract from clinical notes at scale is often what determines whether a real-world evidence study is possible in the first place.

To see how NeuroDiscovery AI works across these real-world data sources, explore.